ADPKD – Landmark Nephrology
Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients Treated With Tolvaptan - Kidney Medicine
Pipeline :: XORTX Therapeutics Inc. (XRTX)
Association of Baseline Urinary Metabolic Biomarkers with ADPKD Severity in TAME-PKD Clinical Trial Participants | American Society of Nephrology
A Randomized Trial of Modified-Release Versus Immediate-Release Tolvaptan in ADPKD - ScienceDirect
Per-Treatment Post Hoc Analysis of Clinical Trial Outcomes With Tolvaptan in ADPKD - ScienceDirect
Treatment Strategies and Clinical Trial Design in ADPKD - Advances in Chronic Kidney Disease
FDA Qualifies Total Kidney Volume as a Prognostic Biomarker for use in Clinical Trials for Polycystic Kidney Disease | Critical Path Institute
ADPKD — Blog — NephJC
Preclinical and clinical trials for identifying treatments for polycystic kidney disease | Polycystic Kidney Disease: from Bench to Bedside
CKD in Autosomic Dominant Polycystic Kidney Disease | IJGM
Matching clinical and genetic diagnoses in autosomal dominant polycystic kidney disease reveals novel phenocopies and potential candidate genes | Genetics in Medicine
CJASN on Twitter: "A Post Hoc Analysis of #Statin Use in Tolvaptan Autosomal Dominant Polycystic Kidney Disease Pivotal Trials https://t.co/vSKnGtOGtv #ADPKD Podcast: https://t.co/C4Np5ZuSSe https://t.co/QOidLSF9tP" / Twitter
Clinical Trial End Points in ADPKD – AJKD Blog
Core Outcome Domains for Trials in Autosomal Dominant Polycystic Kidney Disease: An International Delphi Survey - American Journal of Kidney Diseases
Research Pipeline | PKD Foundation
Medical trials on new therapies for ADPKD. | Download Table
Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD) | BMJ Open
Clinical Trial End Points in ADPKD – AJKD Blog
Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease - Kidney International
Clinical trials of promising re-purposed drugs for ADPKD – Can-SOLVE CKD Network
PLOS ONE: Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease
Autosomal dominant polycystic kidney disease: the changing face of clinical management - The Lancet
Baseline Characteristics and Patient-Reported Outcomes of ADPKD Patients in the Multicenter TAME-PKD Clinical Trial | American Society of Nephrology
